Biodesix to Work with Concentra and Hooper Holmes
Complete the form below to unlock access to ALL audio articles.
The partnerships will provide cancer patients greater and more convenient options for completing VeriStrat testing, a blood-based test that helps physicians guide treatment for patients with non-small cell lung cancer (NSCLC).
To increase the options available to patients whose physicians have ordered VeriStrat, Biodesix is working with Concentra and Hooper Holmes Health and Wellness to collect patient samples for processing in Biodesix’ CLIA accredited central laboratory. The agreement with Concentra will allow patients to access more than 300 Concentra medical centers and laboratory facilities across the U.S. Further increasing options for patients, the partnership with Hooper Holmes provides patients with the convenience of having their blood sample collected in the comfort of their home or location of choice by a certified phlebotomist from Hooper Holmes’ network of over 9,000 local healthcare professionals.
“Biodesix strives to provide patients and physicians with convenient solutions for sample collection,” said Doug Swan, Vice President of Commercial Operations, Biodesix. “Working with Hooper Holmes and Concentra will help to ensure that more patients have access to VeriStrat testing as our test volumes continue to increase.”
The agreements announced today enhance the Company’s ongoing relationships with regional clinical and laboratory service providers across the U.S.
